ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

MANUEL GUERRERO-JIMENEZ MD

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,803Medicare Part D Prescriptions Filled, Including Refills

Rank: 185 out of 1479

$210K Total Retail Price of All Prescriptions

Rank: 314 out of 1479

411 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
2% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

3% of this provider’s 7,129 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

14% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$24 was the average price of a prescription from this provider, compared to $33 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SIMVASTATIN 469 417 1 1
ENALAPRIL MALEATE 337 296 2 3
METFORMIN HCL 322 236 3 2
LOSARTAN-HYDROCHLOROTHIAZIDE 302 251 4 14
AMLODIPINE BESYLATE 276 229 5 6
RANITIDINE HCL 275 200 6 4
LEVOTHYROXINE SODIUM 264 211 7 9
PENTOXIFYLLINE 241 221 8 40
NABUMETONE 202 185 9 22
OMEPRAZOLE 198 155 10 7
LISINOPRIL 174 158 11 16
DICLOFENAC POTASSIUM 168 108 12 29
LISINOPRIL-HYDROCHLOROTHIAZIDE 162 143 13 66
GLIPIZIDE 154 107 14 13
FUROSEMIDE 143 126 15 15
GABAPENTIN 136 96 16 5
ZOLPIDEM TARTRATE 134 103 17 23
TRAMADOL HCL-ACETAMINOPHEN 129 112 18 18
GLYBURIDE MICRONIZED 124 105 R 19 72
AMLODIPINE BESYLATE-BENAZEPRIL 123 106 20 54
METOPROLOL TARTRATE 121 107 21 17
GLIMEPIRIDE 116 92 22 21
AMOXICILLIN 108 78 23 153
ASPIRIN EC 105 94 24 24
MECLIZINE HCL 95 93 25 50
TRAMADOL HCL 92 86 26 20
LOSARTAN POTASSIUM 86 47 27 8
VERAPAMIL ER 81 50 28 34
ALENDRONATE SODIUM 78 74 29 19
ISOSORBIDE MONONITRATE ER 75 63 30 31
ATENOLOL 74 63 31 11
CLOTRIMAZOLE-BETAMETHASONE 74 53 31 39
BACLOFEN 71 49 33 89
HYDROCHLOROTHIAZIDE 68 66 34 10
SERTRALINE HCL 65 47 35 38
HUMULIN 70-30 64 48 36 43
CIPROFLOXACIN HCL 64 55 36 26
DONEPEZIL HCL 62 62 38 45
CAPTOPRIL 59 51 39 28
ETODOLAC 58 28 40 75
HUMULIN N 57 49 41 42
DOXAZOSIN MESYLATE 56 51 42 33
NIFEDIPINE ER 56 56 42 121
NAMENDA 55 55 44 69
INSULIN SYRINGE 54 44 45 30
AZITHROMYCIN 52 41 46 25
ATORVASTATIN CALCIUM 50 46 47 41
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.